For research use only. Not for therapeutic Use.
Kgp-IN-1 hydrochloride is an arginine-specific gingipain (Rgp) inhibitor extracted from patent WO2017201322A1, compound 13-R[1].
| Catalog Number | I014977 |
| CAS Number | 2097865-47-7 |
| Synonyms | N-[(3S)-6-(diaminomethylideneamino)-2-oxo-1-(2,3,5,6-tetrafluorophenoxy)hexan-3-yl]cyclopentanecarboxamide;hydrochloride |
| Molecular Formula | C19H25ClF4N4O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C19H24F4N4O3.ClH/c20-11-8-12(21)16(23)17(15(11)22)30-9-14(28)13(6-3-7-26-19(24)25)27-18(29)10-4-1-2-5-10;/h8,10,13H,1-7,9H2,(H,27,29)(H4,24,25,26);1H/t13-;/m0./s1 |
| InChIKey | PZWDKAZULMZGDB-ZOWNYOTGSA-N |
| SMILES | C1CCC(C1)C(=O)NC(CCCN=C(N)N)C(=O)COC2=C(C(=CC(=C2F)F)F)F.Cl |
| Reference | [1]. Stephen S. Dominy, et al. Treatment of osteoarthritis with gingipain blocking agents. WO2017201322A1. |
